ArticleFrontiers in medicine2022

Two-Week Central Macular Thickness Reduction Rate >37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion.

Jialin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.